Agonists vs Antagonists: Evaluating ADT Efficacy as Monotherapy and Combination Therapy in Hormone-Sensitive Prostate Cancer
Rana McKay, MD
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Ignacio Duran, MD
Sandy Srinivas, MD
Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma
Wenxin Xu, MD
Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer
Susana Campos, MD, MPH
Nicoletta Colombo, MD
Ritu Salani, MD, MBA
Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
Clinical Evidence Behind Emerging Targeted Therapy Strategies Across Gynecologic Malignances
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
Emerging immunotherapy combination strategies in genitourinary malignancies
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Rachelle W. Johnson, PhD
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Constance Lehman, MD, PhD
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
The Potential Link Between COVID-19 and Cancer Regression
Ankit Bharat, MD
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Heather Greenlee, ND, PhD, MPH
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.